Sen. John Hoeven (R-ND) bought $100K-$250K of ABBV stock

John Hoeven, U.S. Senator (R-ND), disclosed a purchase of AbbVie Inc. (NYSE) (ABBV) stock worth $100K-$250K in a STOCK Act filing on Mar 9, 2015.

The trade happened on Feb 25, 2015, 12 days before it was made public.

ABBV has moved +385.7% since the trade date, from $60.62 to $294.45 (Nov 12, 2026 close).